SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002922
Filing Date
2021-11-04
Accepted
2021-11-04 06:51:00
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-20210930.htm   iXBRL 10-Q 2104128
2 EX-31.1 krtx-ex31_1.htm EX-31.1 16811
3 EX-31.2 krtx-ex31_2.htm EX-31.2 16130
4 EX-32.1 krtx-ex32_1.htm EX-32.1 16318
  Complete submission text file 0000950170-21-002922.txt   7121373

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krtx-20210930_pre.xml EX-101.PRE 263412
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krtx-20210930_cal.xml EX-101.CAL 56981
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krtx-20210930.xsd EX-101.SCH 45605
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krtx-20210930_lab.xml EX-101.LAB 382424
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krtx-20210930_def.xml EX-101.DEF 127793
10 EXTRACTED XBRL INSTANCE DOCUMENT krtx-20210930_htm.xml XML 1264485
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 211377887
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences